To capture patients who find the traditional two-visit colonoscopy process too onerous, some practices have implemented “fast-track” colonoscopy programs. Such programs can save patients and practices time and money and open the door to a new group of patients who’ve never been screened. “The whole reason Valley [Health System] embarked on this fast-track colonoscopy program is to increase access to colorectal screening,” Mitchell J. Rubinoff, MD, the chief of gastroenterology at Valley Medical Group in Paramus, N.J., told Gastroenterology & Endoscopy News. From inception, the idea behind the program, Dr. Rubinoff said, was “to get people in who weren’t seeing primary…
Author: Praveen Suthrum
Although fewer patients visited the emergency department for gastrointestinal bleeding during the pandemic, cases were more severe and disproportionately worse among underrepresented groups, according to a study. “As was seen in many other conditions, the early pandemic health care shutdown was associated with a concerning, probably nonbiological decrease in presentation of acute, non-COVID illness to hospital,” Michael K. Dougherty, MD, MSCR, study author and adjunct assistant professor of gastroenterology and hepatology at the University of North Carolina School of Medicine, told Healio. “This suggests that people who may have benefitted from health services were not seeking care for some pandemic-related reason (lack of access,…
A magnetic resonance imaging (MRI) index has been developed and validated for predicting postoperative recurrence (POR) in Crohn disease (CD), according to a study published in the May issue of Clinical Gastroenterology and Hepatology. Marion Schaefer, from Nancy University Hospital in Paris, and colleagues developed and validated an MRI-based index to predict POR in CD. MRI items with good levels of intra- and inter-rater agreement were identified and selected. The MRI in Crohn’s Disease to Predict Postoperative Recurrence (MONITOR) index was assessed in terms of the area under the receiver operating characteristic curve (AUROC) and accuracy. Two radiologists interpreted 73 MRI datasets.
CapsoVision, an innovator in the gastroenterology diagnostics market, and Gastrologix working in conjunction with the Digestive Health Network (DHN), the only gastroenterology specific group purchasing organization (GPO) in the United States, have announced an agreement designating CapsoVision as the primary supplier of capsule endoscopy imaging solutions. CapsoVision will offer CapsoCam Plus®, the only small bowel capsule endoscopy system in the world with a 360° panoramic view, to hundreds of the gastroenterology offices and clinical end users served by Gastrologix across the United States.
For colorectal cancer screening, physicians overwhelmingly prefer colonoscopy, but average-risk adults would likely choose blood tests or at-home stool tests if given the choice, according to survey results presented at the 2022 ASCO Gastrointestinal Cancers Symposium. “When compared to colonoscopy, less invasive modalities, such as blood or stool tests, may be preferred by individuals at average risk but have reduced sensitivity and specificity compared with colonoscopy, such that difficult trade-offs can’t be avoided,” said investigator Sebastian Heidenreich, PhD, the associate director of the patient preference team at Evidera, a global contract research group.
June 4 (Reuters) – The following are summaries of some of the cancer research advances being presented the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Liquid biopsy shows who can skip chemotherapy after colon surgery Liquid biopsy can help identify patients with stage II colon cancer who do not need chemotherapy to prevent recurrence after surgery, according to results of a 455-patient study presented on Saturday.
It is common that Hong Kong people might have experiences of disordered defecation with unknown reason, such as diarrhea and constipation. It is also easy to observe that abdominal discomforts often come along with stress. Emotion disturbance and stress might affect our intestinal functions. The alarm system of our body has been already turned on and expressed as features of Irritable Bowel Syndrome (IBS). Professor Siu-man Ng, Department of Social Work and Social Administration, The University of Hong Kong, points out that the etiology of IBS is not entirely clear. The cause might be related to intestinal abnormality, for examples,…
Endoscopic submucosal dissection and endoscopic mucosal resection with margin ablation should be considered standards of care to reduce recurrence after endoscopic resection of large colorectal polyps, according to a new study. The systematic review and meta-analysis found that local recurrence rates are significantly lower after these procedures than they are with standard endoscopic mucosal resection (EMR). “The optimal resection method for polyps 10 mm or larger has been a matter of debate with the emergence of new resection techniques,” said principal investigator Roupen Djinbachian, MD, a resident at the University of Montreal. “Given this gap in our knowledge, we decided…
Prior authorization is a big part of private practice physicians’ jobs, but it’s among the least popular parts of healthcare for providers of all kinds. The good news: There are signs that reform is gaining momentum. A 2021 AMA survey found 91 percent of physicians said prior authorization can lead to negative clinical outcomes, while 82 percent said it can lead to patients abandoning a course of treatment. Some physicians have seen the ugly side of it firsthand: 34 percent reported that prior authorization has led to a serious adverse event for a patient in their care. Making matters worse, the workload…
Our newest clinical guidelines outline when to use which IBS drug based on your patients’ symptoms. AGA has published two new treatment guidelines in Gastroenterology providing a personalized approach for treating your patients with approved drug treatments for irritable bowel syndrome (IBS) with constipation (IBS-C) or IBS with diarrhea (IBS-D).